Abstract OBJECTIVE: Significant cardiac dysfunction has been found in children with severe hand-foot-mouth disease and heart failure is the major cause of death in these patients. Evaluation of cardiac function is essential for the treatment of severe cases. This study evaluated the clinical value of cardiac output monitoring in children with severe hand-foot-mouth disease. METHODS: A total of 107 children with severe hand-foot-mouth disease admitted to the pediatric intensive care unit from April 2011 to September 2011 were enrolled and divided into three groups by clinical stage: 73 cases in stage 2, 23 cases in stage 3 and 11 cases in stage 4. Cardiac output and stroke volume were measured by ultrasonic cardiac output monitors (USCOM). Ninety-five children received MRI scanning and were grouped according to the results of MRI: 41 cases (medulla oblongata involvements in 9 cases) in abnormal MRI group and 54 cases in normal MRI group. Cardiac output was compared between the children in different clinical stages and between different MRI results. RESULTS: Compared with children in clinical stages 2 and 3, cardiac output in children in clinical stage 4 decreased significantly (P<0.05). There was no differences in cardiac output between the normal and abnormal MRI groups, however cardiac output was significantly lower in children with medulla oblongata involvement than in those with other involvements and normal MRI. CONCLUSIONS: Significant decrease in cardiac output suggests critical conditions and medulla oblongata cardiovascular center involvement in children with severe hand-foot-mouth disease. Dynamic measurement of cardiac output is valuable for treatment of the disease.
CAI Hua-Bo,SONG Ping,ZHANG Lei et al. Clinical application of cardiac output monitoring in children with severe hand-foot-mouth disease[J]. 中国当代儿科杂志, 2012, 14(4): 271-275.
CAI Hua-Bo,SONG Ping,ZHANG Lei et al. Clinical application of cardiac output monitoring in children with severe hand-foot-mouth disease[J]. CJCP, 2012, 14(4): 271-275.
［3］Chang LY, Hsia SH, Huang YC, Lin TY. Left ventricular dysfunction and treatment of fulminat enterovirus 71 infection［J］. Clin Infect Dis, 2002, 35 (11): 1444-1445.
［4］Fu YC, Chi CS, Jan SL, Wang TM, Chen PY, Chang Y, et al. Pulmonary edema of enterovirus 71 encephalomyelitis is associated with left ventricular failure: implications of treatment［J］.Pediatr Pulmonol, 2003, 35 (4): 263-268.
［5］Huang YF, Chiu PC, Chen CC, Chen YY, Hsieh KS, Liu YC, et al. Cardiac troponin I: a reliable marker and early myocardial involvement with meningoencephalitis after fatal enterovirus-71 infection［J］. J Infect, 2003, 46(4): 238-243.
［6］Fu YC, Chi CS, Chiu YT, Hsu SL, Hwang B, Jan SL, et al. Cardiac complications of enterovirus rhombencephalitis［J］. Arch dis Child, 2004, 89（4）: 368-373.
［7］Fu YC, Chi CS, Lin NN, Cheng CC, Jan SL, Hwang B, et al.Comparison of heart failure in children with enterovirus 71 rhombencephalitis and cats with norepinephrine cardiotoxicity［J］. Pediat Cardiol, 2006, 27（5）: 557-584.
［13］Wong KT, Munisamy B, Ong KC, Kojima H, Noriyo N, Chua KB, et al. The distribution of inflammation and virus in human enterovirus. 71 encedphalomyelitis suggests possible viral spread by neural pathways［J］. J Neuropathol Exp Neural, 2008, 67(2):162-169.
［14］Critchlev LA, Peng ZY, Fok BS, Lee A, Phillips RA. Testing the reliability of a new ultrasonic cardiac output monitor, the USCOM, by using aortic flowprobes in anesthetized dogs［J］. Anesth Analg, 2005, 100（3）: 748-753.
［15］Chand R, Mehta Y, Trehan N. Cardiac output estimation with a new Doppler device after off-pump coronary artery bypass surgery［J］. J Cardiothorac Vasc Anesth, 2006, 20（3）: 315-319.
［16］Van Lelyveld-Haas LEM, Van Zanten ARH, Borm GF, Tjian DH. Clinical validation of the non-invasive cardiac output monit or USCOM-1A in critically ill patients［J］. Eur J Anaes thesiol, 2008, 25 (11): 917-924.
